Literature DB >> 15767346

Association of gain and loss of weight before and after menopause with risk of postmenopausal breast cancer in the Iowa women's health study.

Michelle Harvie1, Anthony Howell, Robert A Vierkant, Nagi Kumar, James R Cerhan, Linda E Kelemen, Aaron R Folsom, Thomas A Sellers.   

Abstract

Obesity and adult weight gain are well-established risk factors for postmenopausal breast cancer. Although there are a few studies demonstrating the contribution of adult weight gain to breast cancer risk, whether weight gain during a critical time period is specifically associated with risk, or whether subsequent weight loss among women who have gained weight will reduce the excess risk, is not firmly established. We investigated the association of changes in weight (loss or gain in excess of 5% of body weight) using two risk factor models: (a) age 18 to 30 years and age 30 years to menopause and (b) age 30 years to menopause and after the menopause to the baseline study in 1986 on risk of postmenopausal breast cancer in a prospective cohort of 33,660 postmenopausal women in Iowa. Over 15 years of follow-up, 1,987 cases of breast cancer occurred. Data were analyzed using proportional hazards regression models adjusted for established breast cancer risk factors. The most frequently observed pattern of body weight over time was a consistent increase; these women were observed to have the highest rates of breast cancer and served as the reference category for all comparisons. The lowest-risk groups were (a) women who maintained or lost weight from age 18 to 30 years and then lost weight from age 30 years to menopause [risk ratio (RR), 0.36; 95% confidence interval (95% CI), 0.22-0.60] and (b) women who maintained or lost weight from age 30 years to menopause and then lost weight after the menopause (RR, 0.48; 95% CI, 0.22-0.65). Women who gained weight from age 30 years to menopause but then lost weight after the menopause experienced risk reductions (RR, 0.77; 95% CI, 0.64-0.92) although perhaps slightly smaller in magnitude than women who maintained their weight in both time intervals (RR, 0.63; 95% CI, 0.55-0.73). Women who gained weight from age 18 to 30 years and then lost weight from age 30 years to menopause had comparable risk reductions (RR, 0.61; 95% CI, 0.46-0.8) with women who maintained their weight in both time intervals (RR, 0.73; 95% CI, 0.64-0.84). Women who gained weight during the period from age 30 years to menopause but who had stable weight after menopause had rates similar to the reference group. These data suggest prevention of weight gain between age 18 years and menopause or weight loss and maintenance during these years reduces risk of postmenopausal breast cancer.

Entities:  

Mesh:

Year:  2005        PMID: 15767346     DOI: 10.1158/1055-9965.EPI-04-0001

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  81 in total

Review 1.  Obesity, insulin resistance and diabetes: sex differences and role of oestrogen receptors.

Authors:  M R Meyer; D J Clegg; E R Prossnitz; M Barton
Journal:  Acta Physiol (Oxf)       Date:  2011-02-01       Impact factor: 6.311

Review 2.  Body mass index and breast cancer risk according to postmenopausal estrogen-progestin use and hormone receptor status.

Authors:  Mark F Munsell; Brian L Sprague; Donald A Berry; Gary Chisholm; Amy Trentham-Dietz
Journal:  Epidemiol Rev       Date:  2014       Impact factor: 6.222

3.  Risk Factors That Increase Risk of Estrogen Receptor-Positive and -Negative Breast Cancer.

Authors:  Karla Kerlikowske; Charlotte C Gard; Jeffrey A Tice; Elad Ziv; Steven R Cummings; Diana L Miglioretti
Journal:  J Natl Cancer Inst       Date:  2016-12-31       Impact factor: 13.506

4.  Body mass index and risk of second obesity-associated cancers after colorectal cancer: a pooled analysis of prospective cohort studies.

Authors:  Todd M Gibson; Yikyung Park; Kim Robien; Meredith S Shiels; Amanda Black; Joshua N Sampson; Mark P Purdue; Laura E Beane Freeman; Gabriella Andreotti; Stephanie J Weinstein; Demetrius Albanes; Joseph F Fraumeni; Rochelle E Curtis; Amy Berrington de Gonzalez; Lindsay M Morton
Journal:  J Clin Oncol       Date:  2014-09-29       Impact factor: 44.544

5.  Effects of individual and combined dietary weight loss and exercise interventions in postmenopausal women on adiponectin and leptin levels.

Authors:  C Abbenhardt; A McTiernan; C M Alfano; M H Wener; K L Campbell; C Duggan; K E Foster-Schubert; A Kong; A T Toriola; J D Potter; C Mason; L Xiao; G L Blackburn; C Bain; C M Ulrich
Journal:  J Intern Med       Date:  2013-03-29       Impact factor: 8.989

Review 6.  Weight cycling and cancer: weighing the evidence of intermittent caloric restriction and cancer risk.

Authors:  Henry J Thompson; Anne McTiernan
Journal:  Cancer Prev Res (Phila)       Date:  2011-10-07

7.  Variants of the adiponectin and adiponectin receptor 1 genes and breast cancer risk.

Authors:  Virginia G Kaklamani; Maureen Sadim; Alex Hsi; Kenneth Offit; Carole Oddoux; Harry Ostrer; Habibul Ahsan; Boris Pasche; Christos Mantzoros
Journal:  Cancer Res       Date:  2008-05-01       Impact factor: 12.701

8.  The first national public breast cancer screening program in Saudi Arabia.

Authors:  Omalkhair A Abulkhair; Fatina M Al Tahan; Susan E Young; Salma Ma Musaad; Abdul-Rahman M Jazieh
Journal:  Ann Saudi Med       Date:  2010 Sep-Oct       Impact factor: 1.526

9.  Alcohol and folate intake and breast cancer risk in the WHI Observational Study.

Authors:  Christine M Duffy; Annlouise Assaf; Michele Cyr; Gary Burkholder; Elizabeth Coccio; Tom Rohan; Anne McTiernan; Electra Paskett; Dorothy Lane; V K Chetty
Journal:  Breast Cancer Res Treat       Date:  2008-09-11       Impact factor: 4.872

Review 10.  Prevention of breast cancer in postmenopausal women: approaches to estimating and reducing risk.

Authors:  Steven R Cummings; Jeffrey A Tice; Scott Bauer; Warren S Browner; Jack Cuzick; Elad Ziv; Victor Vogel; John Shepherd; Celine Vachon; Rebecca Smith-Bindman; Karla Kerlikowske
Journal:  J Natl Cancer Inst       Date:  2009-03-10       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.